ARCHIVES

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

“Acceptable” Images Found In Chest Scans Using Half Dose

August 30, 2002

Colorectal Cancer Screening Programs Could Cut Future Treatment Costs

September 25, 2009

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

Breast Cancer Activist, Radiologist Are Added To Special Commission

November 6, 1992

Chemo Can Harm Liver, Affect Surgical Outcomes

May 26, 2006